C. W. Fisher

发表

The Gap between Promise and Reality in Computer Education: Planning a Response.

M. C. Linn, C. W. Fisher, 1984 .

The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein.

C. W. Fisher, R. Estabrook, K. Faulkner, 1995, Archives of biochemistry and biophysics.

Application of electrochemistry for P450-catalyzed reactions.

C. W. Fisher, R. Estabrook, K. Faulkner, 1996, Methods in enzymology.

Maple syrup urine disease in Mennonites. Evidence that the Y393N mutation in E1 alpha impedes assembly of the E1 component of branched-chain alpha-keto acid dehydrogenase complex.

C. W. Fisher, D. Chuang, R. Star, 1991, The Journal of clinical investigation.

A 17-bp insertion and a Phe215----Cys missense mutation in the dihydrolipoyl transacylase (E2) mRNA from a thiamine-responsive maple syrup urine disease patient WG-34.

C. W. Fisher, D. Chuang, C. Fisher, 1991, Biochemical and biophysical research communications.

Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex.

C. W. Fisher, D. Chuang, T. A. Griffin, 1991, Molecular biology & medicine.

Electrocatalytically driven omega-hydroxylation of fatty acids using cytochrome P450 4A1.

C. W. Fisher, R. Estabrook, K. Faulkner, 1995, Proceedings of the National Academy of Sciences of the United States of America.

The interaction of NADPH-P450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain.

C. W. Fisher, M. Waterman, R. Estabrook, 1996, Archives of biochemistry and biophysics.

Cloning and expression in Escherichia coli of mature E1 beta subunit of bovine mitochondrial branched-chain alpha-keto acid dehydrogenase complex. Mapping of the E1 beta-binding region on E2.

C. W. Fisher, D. Chuang, J. Davie, 1992, The Journal of biological chemistry.

Secondary Effect of the Mutations

C. W. Fisher, D. Chuang, C. Fisher, 2006 .

Escherichia coli MTC, a NADPH cytochrome P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450: comparison of three types of expression systems.

C. W. Fisher, N. Vermeulen, R. Estabrook, 1999, Mutation research.

Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.

C. W. Fisher, N. Vermeulen, R. Estabrook, 1999, Mutation research.

Microsomal Cytochrome P450 Levels and Activities of Isolated Rat Livers Perfused with Albumin

C. W. Fisher, R. Shah, R. Mehvar, 2004, Pharmaceutical Research.

Characterization of house fly microsomal mixed function oxidases: inhibition by juvenile hormone i and piperonyl butoxide.

C. W. Fisher, R. Mayer, R. T. Mayer, 1982, Toxicology.

Studies on a fluorescent insect growth regulator metabolite complex with house-fly microsomal cytochrome P-450☆

C. W. Fisher, R. Mayer, A. C. Bridges, 1982 .

The omega-hydroxlyation of lauric acid: oxidation of 12-hydroxlauric acid to dodecanedioic acid by a purified recombinant fusion protein containing P450 4A1 and NADPH-P450 reductase.

C. W. Fisher, R. Estabrook, M. Shet, 1996, Archives of biochemistry and biophysics.

The function of recombinant cytochrome P450s in intact Escherichia coli cells: the 17 alpha-hydroxylation of progesterone and pregnenolone by P450c17.

C. W. Fisher, R. Estabrook, M. Shet, 1997, Archives of biochemistry and biophysics.

Partial purification and characterization of phenobarbital‐induced house fly cytochrome P‐450

C. W. Fisher, R. Mayer, R. T. Mayer, 1983 .

Structure of the gene encoding the entire mature E1α subunit of human branched‐chain α‐keto acid dehydrogenase complex

C. W. Fisher, D. Chuang, R. Cox, 1991, FEBS letters.

Structure of the gene encoding the entire mature E1 alpha subunit of human branched-chain alpha-keto acid dehydrogenase complex.

C. W. Fisher, D. Chuang, R. Cox, 1991, FEBS letters.

Localization of the dihydrolipoamide branched-chain transacylase gene (DBT) of the human branched-chain keto acid dehydrogenase complex to chromosome 1.

C. W. Fisher, R. Eddy, T. Shows, 1991, Cytogenetics and cell genetics.

A review of the biospeleology of Meghalaya, India

C. W. Fisher, D. Harries, J. Biswas, 2008 .

The nucleotide sequence of rabbit liver cytochrome b5 mRNA.

C. W. Fisher, A. Steggles, N. Dariush, 1988, Protein sequences & data analysis.

Metabolism of the antiandrogenic drug (Flutamide) by human CYP1A2.

C. W. Fisher, R. Estabrook, M. Shet, 1997, Drug metabolism and disposition: the biological fate of chemicals.

The high-level expression in Escherichia coli of the membrane-bound form of human and rat cytochrome b5 and studies on their mechanism of function.

C. W. Fisher, R. Estabrook, M. Shet, 1994, Archives of biochemistry and biophysics.

Comparison of the 17α-Hydroxylase/C17,20-Lyase Activities of Porcine, Guinea Pig and Bovine P450c17 Using Purified Recombinant Fusion Proteins Containing P450c17 Linked to NADPH-P450 Reductase

C. W. Fisher, R. Estabrook, A. Conley, 2007, Drug metabolism reviews.

Occurrence of a Tyr393----Asn (Y393N) mutation in the E1 alpha gene of the branched-chain alpha-keto acid dehydrogenase complex in maple syrup urine disease patients from a Mennonite population.

C. W. Fisher, D. Chuang, C. Fisher, 1991, American journal of human genetics.

Hamster hepatic cytochrome b5: purifications, immunochemical properties, and in vitro synthesis.

C. W. Fisher, J. Chiang, A. Steggles, 1985, Biochimica et biophysica acta.

A statistical study of winds and sea water temperatures during Oregon coastal upwelling

C. W. Fisher, 1969 .

High‐level expression of functional human cytochrome P450 1A2 in Escherichia coli

C. W. Fisher, R. Tukey, M. Waterman, 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Human Placental Cytochrome P-450: Microsomal Preparation and Purification

C. W. Fisher, John J. Moore, 1987 .

Characterization of substrate binding to cytochrome P450 1A1 using molecular modeling and kinetic analyses: case of residue 382.

Spencer S Ericksen, Spencer S. Ericksen, C. W. Fisher, 2003, Drug metabolism and disposition: the biological fate of chemicals.

The use of electrochemistry for the synthesis of 17α-hydroxyprogesterone by a fusion protein containing P450c17

C. W. Fisher, R. Estabrook, K. Faulkner, 1996 .

High-level expression in Escherichia coli of enzymatically active fusion proteins containing the domains of mammalian cytochromes P450 and NADPH-P450 reductase flavoprotein.

C. W. Fisher, R. Estabrook, M. Shet, 1992, Proceedings of the National Academy of Sciences of the United States of America.

The effect of reciprocal active site mutations in human cytochromes P450 1A1 and 1A2 on alkoxyresorufin metabolism.

Spencer S Ericksen, Spencer S. Ericksen, C. W. Fisher, 2004, Archives of biochemistry and biophysics.

Molecular Phenotypes in Cultured Maple Syrup Urine Disease Cells

C. W. Fisher, D. Chuang, T. A. Griffin, 1989, The Journal of biological chemistry.

Premature termination of transcription and alternative splicing in the human transacylase (E2) gene of the branched‐chain α‐ketoacid dehydrogenase complex

C. W. Fisher, D. Chuang, R. Cox, 1991, FEBS letters.

Purification and enzymatic properties of a recombinant fusion protein expressed in Escherichia coli containing the domains of bovine P450 17A and rat NADPH-P450 reductase.

C. W. Fisher, M. P. Arlotto, R. Estabrook, 1994, Archives of biochemistry and biophysics.

Prototype Systems Containing Human Cytochrome P450 for High-Throughput Real-Time Detection of DNA Damage by Compounds That Form DNA-Reactive Metabolites.

C. W. Fisher, J. Rueff, M. Kranendonk, 2016, Chemical research in toxicology.

Human cytochrome P450 3A4: enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase.

C. W. Fisher, R. Estabrook, M. Shet, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations.

C. W. Fisher, D. Chuang, C. Fisher, 1993, American journal of human genetics.